3b7dc8223243ae0d9ea66be049d18956

ATELLICA IM VITAMIN B12 DTT/RELEASING AGENT (VB12 DTT/REL)

SIEMENS HEALTHCARE SAS·I·Colombia INVIMA·Expires January 18, 2029

Device classification

Risk class / Clase de Riesgo: I
Product type (Spanish): REACTIVO DIAGNOSTICO
Product type (English): DIAGNOSTIC REAGENT

Registration information

Analysis ID: 3b7dc8223243ae0d9ea66be049d18956
Expire date: January 18, 2029

Authorized company / Fabricante

Name (Spanish): SIEMENS HEALTHCARE SAS
Name (English): SIEMENS HEALTHCARE SAS

Product use / Uso del Producto

Spanish

DETERMINACIÓN DE LOS DIFERENTES ANALITOS RELACIONADOS CON MUESTRAS PROCEDENTES DEL ORGANISMO HUMANO

English

DETERMINATION OF THE DIFFERENT ANALYTES RELATED TO SAMPLES FROM THE HUMAN ORGANISM

About this record

Access comprehensive regulatory information for ATELLICA IM VITAMIN B12 DTT/RELEASING AGENT (VB12 DTT/REL) (ATELLICA IM VITAMIN B12 DTT/RELEASING AGENT (VB12 DTT/REL)) in the Colombia medical device market through Pure Global AI's free database. This I medical device is registered under INVIMA analysis ID 3b7dc8223243ae0d9ea66be049d18956 and manufactured by SIEMENS HEALTHCARE SAS. The device was registered on January 18, 2029.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.